4.6 Article

International validation of the out-of-hospital cardiac arrest score in the United States

期刊

CRITICAL CARE MEDICINE
卷 39, 期 7, 页码 1670-1674

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0b013e318218a05b

关键词

out-of-hospital cardiac arrest; risk score; resuscitation

资金

  1. American Heart Association [0735533T]
  2. Swiss National Foundation [SNF PBBSP3-128266]
  3. University of Basel, Basel, Switzerland
  4. Robert Wood Johnson Foundation [66350]
  5. American Heart Association for corticosteroids in postcardiac arrest shock

向作者/读者索取更多资源

Objective: Investigators in France have developed a risk score to predict death or poor neurologic outcome after out-of-hospital cardiac arrest. The aim of this study is to externally validate this score in an independent patient population in the United States. Design: Retrospective, observational, cohort study. Patients: Patients being admitted to the intensive care unit after out-of-hospital cardiac arrest. Setting: Two geographically distinct tertiary care hospitals in the United States. Interventions: None. Measurements and Main Results: The primary end point was poor outcome, defined as either death or a Cerebral Performance Category score of 3-5. The secondary end point was all-cause mortality. Calibration was assessed by comparing the number of expected outcomes based on the logistic model of the French study with observed outcomes within this study using Hosmer-Lemeshow C test (goodness-of-fit). Discrimination was assessed by calculation of the area under the receiver operating characteristic curve. Of a total of 128 patients, 99 (77%) had a poor outcome, including 91 nonsurvivors (71%). The probability of poor neurologic outcome and mortality increased stepwise with increasing out-of-hospital cardiac arrest score. Graphic display of observed against predicted outcomes and goodness-of-fit test indicated good calibration of the score (p =.4). The score showed good discrimination for poor outcome (area under the receiving operating characteristic curve, 0.85; 95% confidence interval, 0.79-0.92) and for mortality (area under the receiving operating characteristic curve, 0.85; 95% confidence interval, 0.78-0.91). In patients with an out-of-hospital cardiac arrest score > 40 points and > 60 points, the positive predictive value for poor outcome was 97% and 100%, respectively. Conclusions: This study found good calibration and high discrimination of the out-of-hospital cardiac arrest score in two geographically distinct patient populations in the United States. Particularly, this score had a high positive predictive value and performed well in identifying high-risk patients for poor outcomes. (Crit Care Med 2011; 39: 1670-1674)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis

Carmen de Jesus-Gil, Lidia Sans-de San Nicolas, Ester Ruiz-Romeu, Marta Ferran, Laura Soria-Martinez, Irene Garcia-Jimenez, Anca Chiriac, Josep Manel Casanova-Seuma, Josep Manel Fernandez-Armenteros, Sherry Owens, Antonio Celada, Michael D. Howell, Ramon Maria Pujol, Luis Francisco Santamaria-Babi

Summary: The study found that patients with plaque psoriasis have higher levels of anti-CA IgA and IgG in their plasma, and the cellular response to Candida albicans primarily occurs in CLA(+) T cells, particularly Th17 cells. In plaque psoriasis, the levels of anti-CA IgA are directly associated with the CLA(+) Th17 response. Proteomic analysis revealed distinct profiles in psoriasis patients with high anti-CA IgA levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Medicine, General & Internal

Lessons From the Health Information Technology for Economic and Clinical Health (HITECH) Act

Kushal T. Kadakia, Michael D. Howell, Karen B. DeSalvo

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Letter Dermatology

PD-L1 Triggered by Binding eIF3I Contributes to the Amelioration of Diabetes-Associated Wound Healing Defects by Regulating IRS4 Response

Darrell S. Rigel, John W. Whitaker, Maral K. Skelsey, Gary Peck, Michael D. Howell, Burkhard Jansen

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Health Care Sciences & Services

Privacy-first health research with federated learning

Adam Sadilek, Luyang Liu, Dung Nguyen, Methun Kamruzzaman, Stylianos Serghiou, Benjamin Rader, Alex Ingerman, Stefan Mellem, Peter Kairouz, Elaine O. Nsoesie, Jamie MacFarlane, Anil Vullikanti, Madhav Marathe, Paul Eastham, John S. Brownstein, Blaise Aguera Y. Arcas, Michael D. Howell, John Hernandez

Summary: Privacy protection is crucial in health research, and federated learning techniques allow for building machine learning models in a distributed manner to ensure data security. Studies have shown that federated models can achieve similar accuracy and generalizability as standard centralized statistical models, while providing stronger privacy protections.

NPJ DIGITAL MEDICINE (2021)

Article Dermatology

Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies

Afsaneh Alavi, Iltefat Hamzavi, Kurt Brown, Leandro L. Santos, Zhaoyin Zhu, Huiqing Liu, Michael D. Howell, Joslyn S. Kirby

Summary: This study described the safety and efficacy results of the JAK1 inhibitor INCB054707 in patients with moderate-to-severe HS. The results showed that the drug was well tolerated and demonstrated therapeutic effects in patients with moderate-to-severe HS. These findings provide proof of concept for the use of JAK1 inhibitors in the treatment of HS.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Medicine, General & Internal

Patient and Clinician Perceptions of Factors Relevant to Ideal Specialty Consultations

Stephanie D. Roche, Anna C. Johansson, Jaclyn Giannakoulis, Michael N. Cocchi, Michael D. Howell, Bruce Landon, Jennifer P. Stevens

Summary: This study aimed to understand the ideal inpatient consultation and identify the reasons for common failures in consultation. The study found that successful inpatient consultation requires a series of complex and time-sensitive information exchanges, which are vulnerable to failure. Improving consultation quality will require not only reducing low-value consultations but also actively preventing common defects such as information inaccuracies and misinterpretation.

JAMA NETWORK OPEN (2022)

Letter Allergy

SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis

Lidia Sans-De San Nicolas, Ignasi Figueras-Nart, Montserrat Bonfill-Orti, Carmen De Jesus-Gil, Irene Garcia-Jimenez, Antonio Guilabert, Laia Curto-Barredo, Marta Bertolin-Colilla, Marta Ferran, Esther Serra-Baldrich, Anna Zalewska-Janowska, Yui-Hsi Wang, Michael D. Howell, Ramon M. Pujol, Luis F. Santamaria-Babi

ALLERGY (2022)

Article Hematology

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease

Michael Pratta, Sophie Paczesny, Gerard Socie, Natalie Barkey, Hao Liu, Sherry Owens, Michael C. Arbushites, Mark A. Schroeder, Michael D. Howell

Summary: This study identified 7 candidate biomarkers using a broad proteomic analysis, in which MCP3, ProCALCA/CALCA, and REG3A could stratify responders and non-responders to itacitinib in acute GVHD, while ProCALCA/CALCA, ST2, and TNFR1 could serve as response-to-treatment biomarkers.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Meeting Abstract Dermatology

SEB-INDUCED IL-13 PRODUCTION IN CLA plus MEMORY T-CELLS DEFINES TH2 HIGH AND TH2 LOW RESPONDERS IN ATOPIC DERMATITIS

Lidia Sans-De San Nicolas, Ignasi Figueras-Nart, Montserrat Bonfill-Orti, Carmen De Jesus-Gil, Irene Garcia-Jimenez, Antonio Guilabert-Vidal, Laia Curto-Barredo, Marta Bertolin-Colilla, Marta Ferran, Esther Serra-Baldrich, Anna Zalewska-Janowska, Yui-Hsi Wang, Michael D. Howell, Ramon M. Pujol, Luis F. Santamaria-Babi

ACTA DERMATO-VENEREOLOGICA (2022)

Letter Dermatology

A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation

Pearl E. Grimes, Jag Bhawan, Michael D. Howell, Seemal Desai, Edna Coryell, Rama Nashawati, Michael Einziger, Ann Marie Simpson, Alex Yaroshinsky, Tim Mc Craw

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Meeting Abstract Dermatology

A novel expression-based, noninvasive method to differentiate atopic dermatitis and psoriasis

Michael D. Howell, Ramesh Ratnappan, Talisha Allen, James Rock, John W. Whitaker

BRITISH JOURNAL OF DERMATOLOGY (2022)

Meeting Abstract Dermatology

A randomized, placebo-controlled, phase 2 study of the Janus Kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa

Afsaneh Alavi, Iltefat Hamzavi, Kurt Brown, Leandro L. Santos, Zhaoyin Zhu, Michael D. Howell, Joslyn Kirby

EXPERIMENTAL DERMATOLOGY (2021)

Meeting Abstract Dermatology

Association between an itch-free state in atopic dermatitis treated with ruxolitinib cream and systemic inflammatory mediators

Sherry Owens, Heather Jones, Michael E. Kuligowski, Michael D. Howell

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Article Medicine, General & Internal

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin, Amit G. Pandya, Mark Lebwohl, Pearl Grimes, Iltefat Hamzavi, Alice B. Gottlieb, Kathleen Butler, Fiona Kuo, Kang Sun, Tao Ji, Michael D. Howell, John E. Harris

LANCET (2020)

Meeting Abstract Hematology

Predicting Complete Response to Itacitinib and Corticosteroids in Acute Graft Versus Host Disease

Michael Pratta, Hao Liu, Sherry Owens, Ying Yan, Michael Arbushites, Michael D. Howell

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

暂无数据